In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening. The finding suggests a possible new treatment option for people with the slow-growing, deadly brain tumor.
from Medical Xpress - latest medical and health news stories https://ift.tt/aV5Th73
